Temporary Alopecia After Endovascular Treatment Related to a Facial Arteriovenous Malformation: Case Report

    March 2024 in “ Arquivos de Ciências da Saúde da UNIPAR ”
    Danielly Bernardes Silva, Arthur Barroso Vidal Vilarinho, Ana Rosária Medeiros Peres, Rodolfo Loureiro Borges de Souza, Murillo Felisberto Morais de Assunção, Fábio Lemos Campedelli, Carlos Eduardo de Sousa Amorelli, Fábio Augusto Cypreste Oliveira
    TLDR Onyx® embolization effectively treats facial arteriovenous malformations with minimal complications.
    This case report describes a 34-year-old male who experienced temporary alopecia following endovascular treatment for an arteriovenous malformation on the face. The treatment involved diagnostic arteriography and embolization with Onyx®, a procedure performed successfully without complications. Three weeks post-procedure, the patient developed localized hair loss in the right occipitoparietal region, which was treated with topical Minoxidil and oral Cilostazol. Hair regrowth occurred spontaneously within 2 months. The study concludes that Onyx® embolization is an effective therapeutic option for facial arteriovenous malformations, preserving critical structures and having a low complication rate in the medium to long term.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 922 results

      community 22M - Doctor Said Hair Loss From Stress, Minoxidil Helped But Now It’s Back Worse. What Now?

      in General  117 upvotes 7 months ago
      A 22-year-old experiencing hair loss, initially attributed to stress, found temporary relief with minoxidil but faced increased shedding after stopping and restarting the treatment. The advice given suggests the hair loss may be due to androgenic alopecia rather than stress, recommending consistent use of minoxidil and considering finasteride, with a suggestion to seek a second opinion from another dermatologist.

      community Journey against alopecia - Finasteride 3 month

      in Progress Pictures  17 upvotes 4 years ago
      A 26-year-old man from France started experiencing hair loss in September 2020 and began using finasteride in June 2021, reporting some improvement after three months without side effects. He plans to continue finasteride for a year before considering additional treatments like minoxidil or dermarolling.

      community any news about DUPA (Diffuse unpatterned alopecia)?

      in Research/Science  8 upvotes 2 years ago
      The conversation discusses diffuse unpatterned alopecia (DUPA) and its possible causes, including sensitivity to DHT, not being androgenic alopecia, being diffuse alopecia areata, or hormonal issues. Treatments mentioned include topical melatonin, Clobetasol Propionate for alopecia areata, and the lack of results from using finasteride, dutasteride, and minoxidil.

      community Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China

      in Technology  13 upvotes 4 years ago
      The conversation discusses the approval of Kintor Pharmaceutical's AR-PROTAC (GT20029) for clinical trials in China for acne and androgenic alopecia. One user expresses optimism about new treatments being developed and seeks clarification on how the new drug works, specifically if it temporarily degrades the AR protein to reduce DHT sensitivity in hair follicles.

    Similar Research

    5 / 1000+ results